Levamlodipine Maleate

CHEMBL4594288 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
524.9 g/mol
LogP
Phase
4

A maleate salt form of levamlodipine, the active levorotatory enantiomer of amlodipine, used to treat high blood pressure and angina. By blocking calcium channels in blood vessel walls, it causes relaxation and widening of arteries, lowering blood pressure.

Peso molecular

524,9000 g/mol

TPSA

174,00 Ų

Áreas terapéuticas

Mecanismo de acción

Blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac myocytes, reducing calcium influx during depolarization. This produces vasodilation, decreased myocardial contractility, and reduced heart rate.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac myocytes, reducing calcium influx during depolarization. This produces vasodilation, decreased myocardial contractility, and reduced heart rate.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl.O=C(O)/C=C\C(=O)O

InChI

InChI=1S/C20H25ClN2O5.C4H4O4/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21;5-3(6)1-2-4(7)8/h5-8,17,23H,4,9-11,22H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t17-;/m0./s1

Molecular Formula

C24H29ClN2O9

HBD / HBA

4 / 11

Enlaces Rotables

12

Átomos Pesados

36

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A maleate salt form of levamlodipine, the active levorotatory enantiomer of amlodipine, used to treat high blood pressure and angina. By blocking calcium channels in blood vessel walls, it causes relaxation and widening of arteries, lowering blood pressure.

Blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac myocytes, reducing calcium influx during depolarization. This produces vasodilation, decreased myocardial contractility, and reduced heart rate.

Yes, Levamlodipine Maleate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4594288. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 69165622. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.